Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Artigo em Chinês | WPRIM | ID: wpr-1024397

RESUMO

Objective To compare the effects and prognosis between bivalirudin and heparin on coronary microcirculation in patients with acute coronary syndrome(ACS)during percutaneous coronary intervention(PCI).Methods A retrospective analysis was conducted on 312 ACS patients who underwent PCI treatment in the Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University from January 2020 to March 2023.General clinical data were analyzed and divided into a bivalvrudin group of 153 patients and a heparin group of 159 patients based on different anticoagulation regimens during the perioperative period.The postoperative thrombolysis in myocardial infarction(TIMI)blood flow grading,TIMI myocardial perfusion grading(TMPG),ST segment regression rate(STR)of electrocardiogram,and the number of angina pectoris episodes were observed and compared between the two groups The incidence of adverse events within 7 days after surgery,the incidence of major adverse cardiovascular events(MACE)within 3 months after surgery,and the incidence of bleeding events.Results There was no statistically significant difference in the general clinical data and intraoperative conditions between the two groups of patients(both P>0.05).There was no statistically significant difference in TIMI blood flow grading between the two groups of patients after PCI(P=0.959).The TMPG grading of two groups of patients after PCI was statistically significant(P=0.001).The number of angina attacks and ST segment regression rate of electrocardiogram in both groups of patients after PCI were statistically significant(both P<0.05).The incidence of adverse events within 7 days after PCI in two groups of patients was not statistically significant(P=0.285).There was no statistically significant difference in the total incidence of MACE events within 3 months after PCI between the two groups of patients(P=0.195).There was no statistically significant difference in the incidence of bleeding events within 3 months after PCI between the two groups of patients(all P>0.05).Conclusions sivalirudin is safe and effective for PCI treatment,can improve coronary microcirculation,and does not increase the incidence of MACE events,bleeding events,and stent thrombosis events.

2.
Artigo em Chinês | WPRIM | ID: wpr-878426

RESUMO

OBJECTIVES@#The present study aimed to explore the innervation of the anterior hard palatine and its relationship with individual development stage. Specifically, the effects of anesthesia on patients of different ages were observed, and neurodevelopment in the maxillofacial region was invesitgated. References that are helpful in selecting local anesthesia were provided.@*METHODS@#A total of 182 patients with mixed dentition were randomly divided into the nasopalatine nerve block and greater palatine nerve block groups. Then, 219 patients with permanent dentition were divided into an adolescent group (13-18 years old) and adult group (over 19 years old), all of whom underwent bilateral greater palatine nerve block. Palatal mucosal pain sensation was tested pre- and post-anesthesia with Von Frey hairs.@*RESULTS@#Among the children with mixed dentition, bilateral greater palatine nerve block tended to result in better anesthetic effects than nasopalatine nerve block (@*CONCLUSIONS@#The sensation of the anterior hard palatine seems mainly dominated by the greater palatine nerve until mixed dentition and gradually shifted to the nasopalatine nerve in conjunction with maxillary development and tooth replacement. Hence, the innervation of the anterior hard palatine induce a secondary development during the development of the maxilla.


Assuntos
Adolescente , Adulto , Criança , Humanos , Adulto Jovem , Dentição Mista , Maxila , Nervo Maxilar , Bloqueio Nervoso , Palato , Palato Duro
3.
Artigo em Inglês | WPRIM | ID: wpr-719646

RESUMO

BACKGROUND: We examined changes in hepatitis B core-related antigen (HBcrAg) during the four sequential phases of chronic hepatitis B virus (HBV) infection: hepatitis B e antigen (HBeAg)-positive chronic infection (EPCI) and hepatitis (EPCH), followed by HBeAg-negative chronic infection (ENCI) and hepatitis (ENCH). We compared the performance of serum HBcrAg, hepatitis B surface antigen (HBsAg), and HBV DNA in predicting EPCH and ENCH. METHODS: We enrolled 492 consecutive patients: 49 with EPCI, 243 with EPCH, 101 with ENCI, and 99 with ENCH. HBcrAg was detected by chemiluminescent enzyme immunoassays. HBsAg and HBeAg were detected by chemiluminescent microparticle immunoassays. HBV DNA was detected by real-time PCR. Predictive performance of HBcrAg, HBsAg, and HBV DNA was evaluated using ROC curves. RESULTS: Areas under ROC curves (AUCs) of HBcrAg, HBsAg, and HBV DNA for predicting EPCH were 0.738, 0.812, and 0.717, respectively; optimal cutoffs were ≤1.43×105 kU/mL, ≤1.89×104 IU/mL, and ≤3.97×107 IU/mL, with sensitivities and specificities of 66.3% and 77.6%, 65.0% and 93.9%, and 60.5% and 79.6%, respectively. AUCs of HBcrAg, HBsAg, and HBV DNA for predicting ENCH were 0.887, 0.581, and 0.978, respectively; optimal cutoffs were >26.8 kU/mL, >2.29×102 IU/mL, and >8.75×103 IU/mL, with sensitivities and specificities of 72.7% and 95.1%, 86.9% and 39.6%, and 89.9% and 92.1%, respectively. CONCLUSIONS: HBsAg and HBV DNA were the best predictors of EPCH and ENCH, respectively. HBcrAg is an important surrogate marker for predicting EPCH and ENCH.


Assuntos
Humanos , Área Sob a Curva , Biomarcadores , DNA , Antígenos E da Hepatite B , Antígenos de Superfície da Hepatite B , Vírus da Hepatite B , Hepatite B , Hepatite B Crônica , Hepatite , Hepatite Crônica , Imunoensaio , Técnicas Imunoenzimáticas , Reação em Cadeia da Polimerase em Tempo Real , Curva ROC
4.
Artigo em Chinês | WPRIM | ID: wpr-710213

RESUMO

AIM To investigate the effects of Tongxinluo Capsules (Ginseng Radix et Rhizoma,Hirudo,Scorpio,etc.) combined with routine treatment on fibrinogen (Fib) and mean platelet volume (MPV) levels in appropriate patients for coronary artery bypass graft (CABG) surgery.METHODS One hundred and six patients were randomly assigned into control group (n =50) for routine treatment and observation group (n =56) for combination therapy of Tongxinluo Capsules and routine treatment.Both groups had their Fib and MPV levels evaluated,and safety compared.RESULTS Thirty,ninety days after the treatment,the two groups reported less incidence of composite cardiovascular events (refractory angina pectoris,relapsing myocardial infarction or death) (P < 0.01),and the observation group had an even more obviously reduced plasma Fib level (P <0.01).The significantly decreased after-treatment MPV levels in the two groups were observed (P < 0.05),and a most distinct decrease extent was found in the observation group after 90 d (P < 0.05).For the bleeding events,the incidence rates of the observation group and the control group were 5.4% and 4.0%,respectively.CONCLUSION For appropriate candidates of CABG surgery,Tongxinluo Capsules shows its efficacy in dissolving thrombus and improving clinical symptoms without serious bleeding risk.

SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa